These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2961247)

  • 21. Left ventricular hypertrophy sensitizes the myocardium to the development of ischaemia.
    Salcedo EE; Marwick TH; Korzick DH; Goormastic M; Go RT
    Eur Heart J; 1990 Nov; 11 Suppl G():72-8. PubMed ID: 2150039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of dipyridamole stress echocardiography in hypertensive patients with left ventricular hypertrophy, chest pain and resting electrocardiographic repolarization abnormalities.
    Mondillo S; Agricola E; Ammaturo T; Guerrini F; Barbati R; Focardi M; Picchi A; Ballo P; Nami R
    Can J Cardiol; 2001 May; 17(5):571-7. PubMed ID: 11381279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic implications of left ventricular hypertrophy in arterial hypertension].
    Kannel WB
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():11-21. PubMed ID: 2150470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
    Strauer BE; Bayer F; Brecht HM; Motz W
    J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary vascular changes in the progression and regression of hypertensive heart disease.
    Strauer BE; Schwartzkopff B; Motz W; Vogt M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S20-7. PubMed ID: 1720480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effectiveness of long-term treatment of patients with hypertension].
    Gurgenian SV; Mikaelian ES; Pogosian SA; Babaian AS; Arutiunian EA
    Ter Arkh; 1988; 60(2):89-92. PubMed ID: 2966992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptomatic and silent myocardial ischaemia in hypertensive patients with left ventricular hypertrophy.
    Pringle SD; Dunn FG; Tweddel AC; Martin W; Macfarlane PW; McKillop JH; Lorimer AR; Cobbe SM
    Br Heart J; 1992 May; 67(5):377-82. PubMed ID: 1389717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transient subendocardial ischemia in abolition of hypertensive crises with nifedipine].
    Ivleva AIa; Kobalava ZsD ; Demidenko IV; Krasnobaeva GM; Strugovshchikov AN; Moĭseev VS
    Kardiologiia; 1991 Nov; 31(11):21-3. PubMed ID: 1839560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of cardiac risk in hypertensive patients with left heart hypertrophy].
    Schulte KL; Meyer-Sabellek W; Liederwald K; Eisenhut C; Distler A; Gotzen R
    Z Kardiol; 1991; 80 Suppl 1():37-40. PubMed ID: 1827230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Left ventricular hypertrophy in arterial hypertension].
    Garnier LF; François G; Lang M; Raynaud P; Brochier M
    Presse Med; 1988 Feb; 17(7):333-8. PubMed ID: 2966353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Coronary microangiopathy in hypertensive heart disease: pathogenesis, diagnosis and therapy].
    Motz W; Scheler S; Strauer BE
    Herz; 1995 Dec; 20(6):355-64. PubMed ID: 8582695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of left ventricular hypertrophy secondary to systemic hypertension on left coronary artery flow dynamics.
    Tadaoka S; Wada Y; Kimura A; Yada T; Tamura K; Hasegawa K; Nezuo S; Sawayama T; Tsujioka K; Kajiya F
    Cardiovasc Res; 1991 Nov; 25(11):955-64. PubMed ID: 1839891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of long-term cardiac hypertrophy on coronary vasodilator reserve in SHR rats.
    Peters KG; Wangler RD; Tomanek RJ; Marcus ML
    Am J Cardiol; 1984 Dec; 54(10):1342-8. PubMed ID: 6239536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of left ventricular geometry on coronary vasomotion in patients with essential hypertension.
    Sekiya M; Funada J; Suzuki J; Watanabe K; Miyagawa M; Akutsu H
    Am J Hypertens; 2000 Jul; 13(7):789-95. PubMed ID: 10933571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ["Silent" myocardial ischemia and the activity of the sympathetic-adrenal system in hypertension patients].
    Iurenev AP; De Quattro V; Titov VN; Guliaev VP; Kuz'min AI; Koniaeva EB
    Ter Arkh; 1991; 63(9):83-7. PubMed ID: 1836901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular hypertrophy resulting from systemic hypertension: adaptive advantage and adverse consequences.
    Taylor AL
    J Assoc Acad Minor Phys; 1991; 2(4):156-61. PubMed ID: 1839825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertension and coronary artery disease. Can the chain be broken?
    Dunn FG; Pringle SD
    Hypertension; 1991 Sep; 18(3 Suppl):I126-32. PubMed ID: 1832413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Coronary effects of left ventricular hypertrophy associated with hypertension].
    Trimarco B; de Luca N; Ricciardelli B; Rosiello G; Lembo G; Rendina V; Raponi M; Marchegiano R; Volpe M
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():63-6. PubMed ID: 2150476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regression of left ventricular mass in systemic hypertension.
    Georgiou D; Brundage BH
    Clin Cardiol; 1992 Jan; 15(1):5-16. PubMed ID: 1531790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of abnormalities in coronary flow reserve to the pathophysiology of left ventricular hypertrophy secondary to hypertension.
    Marcus ML
    Clin Cardiol; 1989 Dec; 12(12 Suppl 4):IV34-5. PubMed ID: 2533528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.